Ernexa Therapeutics Inc. Payments of Debt Issuance Costs
Ernexa Therapeutics Inc. (ERNA) had Payments of Debt Issuance Costs of $66.00 thousand as of 2024-01-11, per its 10-K filed 2025-03-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2025-03-12
- Ernexa Therapeutics Inc. payments of debt issuance costs for the quarter ending 2020-12-31 was $0.00.
- Ernexa Therapeutics Inc. payments of debt issuance costs for the quarter ending 2020-09-30 was $0.00.
- Ernexa Therapeutics Inc. payments of debt issuance costs for the quarter ending 2020-06-30 was $0.00.
- Ernexa Therapeutics Inc. payments of debt issuance costs for the quarter ending 2020-03-31 was $3.00K.
- Ernexa Therapeutics Inc. payments of debt issuance costs for fiscal 2020 was $3.00K.
- Ernexa Therapeutics Inc. payments of debt issuance costs for fiscal 2018 was $23.00K, a 71.95% decline from fiscal 2017.
- Ernexa Therapeutics Inc. payments of debt issuance costs for fiscal 2017 was $82.00K, a 811.11% increase from fiscal 2016.
- Ernexa Therapeutics Inc. payments of debt issuance costs for fiscal 2016 was $9.00K, a 88.89% decline from fiscal 2015.
| Period end | Payments of Debt Issuance Costs | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2024-01-11 | $66.00K 10-K · filed 2025-03-12 | ||||
| 2023-12-15 | $166.00K 10-K · filed 2025-03-12 | ||||
| 2023-07-14 | $201.00K 10-K · filed 2025-03-12 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $0.00 derived: sum of 2 quarters · filed 2021-03-11 | $0.00 derived: sum of 3 quarters · filed 2021-03-11 | $3.00K 10-K · filed 2021-03-11 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $3.00K 10-Q · filed 2020-11-13 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $3.00K 10-Q · filed 2020-08-07 | |||
| 2020-03-31 | $3.00K 10-Q · filed 2020-05-20 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $23.00K 10-K · filed 2020-03-19 | |||
| 2018-09-30 | $23.00K 10-Q · filed 2019-11-01 | ||||
| 2017-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $60.00K derived: sum of 2 quarters · filed 2019-03-22 | $60.00K derived: sum of 3 quarters · filed 2019-03-22 | $82.00K 10-K · filed 2019-03-22 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $0.00 derived: sum of 2 quarters · filed 2018-11-09 | $22.00K 10-Q · filed 2018-11-09 | $23.00K derived: sum of 4 quarters · filed 2018-11-09 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $22.00K 10-Q · filed 2018-08-06 | $23.00K derived: sum of 3 quarters · filed 2018-08-06 | $29.00K derived: sum of 4 quarters · filed 2018-08-06 | |
| 2017-03-31 | $22.00K 10-Q · filed 2018-05-11 | $23.00K derived: sum of 2 quarters · filed 2018-05-11 | $29.00K derived: sum of 3 quarters · filed 2018-05-11 | $26.00K derived: sum of 4 quarters · filed 2018-05-11 | |
| 2016-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $7.00K derived: sum of 2 quarters · filed 2018-03-09 | $4.00K derived: sum of 3 quarters · filed 2018-03-09 | $9.00K 10-K · filed 2018-03-09 | |
| 2016-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $3.00K derived: sum of 2 quarters · filed 2017-11-08 | $8.00K 10-Q · filed 2017-11-08 | $8.00K derived: sum of 4 quarters · filed 2017-11-08 | |
| 2016-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $2.00K 10-Q · filed 2017-08-04 | $2.00K derived: sum of 3 quarters · filed 2017-08-04 | $2.00K derived: sum of 4 quarters · filed 2017-08-04 | |
| 2016-03-31 | $5.00K 10-Q · filed 2017-05-04 | $5.00K derived: sum of 2 quarters · filed 2017-05-04 | $5.00K derived: sum of 3 quarters · filed 2017-05-04 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $0.00 derived: sum of 2 quarters · filed 2017-03-09 | $81.00K 10-K · filed 2017-03-09 | ||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $81.00K 10-Q · filed 2016-11-09 | |||
| 2015-06-30 | $81.00K 10-Q · filed 2016-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |